ERS/ATS technical standard on interpretive strategies for routine lung function tests

S Stanojevic, DA Kaminsky, MR Miller… - European …, 2022 - Eur Respiratory Soc
Background Appropriate interpretation of pulmonary function tests (PFTs) involves the
classification of observed values as within/outside the normal range based on a reference …

Monitoring fatigue status in elite team-sport athletes: implications for practice

RT Thorpe, G Atkinson, B Drust… - … journal of sports …, 2017 - journals.humankinetics.com
The increase in competition demands in elite team sports over recent years has prompted
much attention from researchers and practitioners to the monitoring of adaptation and …

Home oxygen therapy for adults with chronic lung disease. An official American Thoracic Society clinical practice guideline

SS Jacobs, JA Krishnan, DJ Lederer… - American journal of …, 2020 - atsjournals.org
Background: Evidence-based guidelines are needed for effective delivery of home oxygen
therapy to appropriate patients with chronic obstructive pulmonary disease (COPD) and …

Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised …

A Papi, J Vestbo, L Fabbri, M Corradi, H Prunier… - The Lancet, 2018 - thelancet.com
Background Evidence is scarce on the relative risk-benefit of inhaled triple therapy,
consisting of inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting β 2 …

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel …

J Vestbo, A Papi, M Corradi, V Blazhko, I Montagna… - The Lancet, 2017 - thelancet.com
Background Limited data are available for the efficacy of triple therapy with two long-acting
bronchodilators and an inhaled corticosteroid in chronic obstructive pulmonary disease …

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind …

D Singh, A Papi, M Corradi, I Pavlišová, I Montagna… - The Lancet, 2016 - thelancet.com
Background Few data are available for the efficacy of" triple therapy" with two long-acting
bronchodilators and an inhaled corticosteroid in chronic obstructive pulmonary disease …

Management of COPD exacerbations: a European respiratory society/American thoracic society guideline

JA Wedzicha, M Miravitlles, JR Hurst… - European …, 2017 - Eur Respiratory Soc
This document provides clinical recommendations for treatment of chronic obstructive
pulmonary disease (COPD) exacerbations. Comprehensive evidence syntheses, including …

Pulmonary rehabilitation for interstitial lung disease

L Dowman, CJ Hill, A May… - Cochrane database of …, 2021 - cochranelibrary.com
Background Interstitial lung disease (ILD) is characterised by reduced functional capacity,
dyspnoea and exercise‐induced hypoxia. Pulmonary rehabilitation is often used to improve …

European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD

B Ergan, S Oczkowski, B Rochwerg… - European respiratory …, 2019 - Eur Respiratory Soc
Background While the role of acute non-invasive ventilation (NIV) has been shown to
improve outcome in acute life-threatening hypercapnic respiratory failure in COPD, the …

Inhaled corticosteroids in COPD: friend or foe?

A Agusti, LM Fabbri, D Singh, J Vestbo… - European …, 2018 - Eur Respiratory Soc
The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …